首页 | 本学科首页   官方微博 | 高级检索  
检索        

Neuregulin-1β对压力超负荷心肌肥大大鼠治疗作用及机制的研究
引用本文:刘延峰,刘小娟,惠起源.Neuregulin-1β对压力超负荷心肌肥大大鼠治疗作用及机制的研究[J].中国病理生理杂志,2013,29(4):609-614.
作者姓名:刘延峰  刘小娟  惠起源
作者单位:1延安大学医学院, 2延安市卫生学校, 陕西 延安 716000
摘    要: 目的:研究神经调节蛋白 1β(NRG-1β)对压力超负荷所致大鼠心肌肥大的治疗作用并探讨其机制。方法:Wistar雄性大鼠采用腹主动脉缩窄的方法复制心肌肥大模型。术后8周,将模型动物随机分成模型(model)组、NRG-1β治疗组(尾静脉注射NRG-1β,10 μg·kg-1·d-1)和NRG-1β+赫赛汀(Herceptin, HERCE)治疗组(尾静脉注射NRG-1β的同时给予注射HERCE 10 μg·kg-1·d-1)。假手术(sham)组除不以银夹缩窄腹主动脉外,其余操作同腹主动脉缩窄组。7 d后分别采用心动超声、血流动力学评价心功能;Masson染色观察心肌组织的超微结构;放射免疫法检测心肌组织中血管紧张素II(Ang II),酶联免疫吸附法测定心肌组织中肿瘤坏死因子 α(TNF-α)的变化;RT-PCR法检测心肌中bcl-2和bax mRMA表达的改变。结果:(1)心动超声显示,和模型组比较,NRG-1β组左室射血分数(LVEF)及短轴缩短率(LVFS)升高,左室收缩末内径(LVESD)及舒张末内径(LVEDD)减小(P<0.01)。(2)血流动力学检测显示,NRG-1β治疗组左室收缩末压(LVESP)和左室内压最大上升和下降速率(±dp/dtmax)均明显高于模型组(P<0.01);左室舒张末压(LVEDP)低于模型组(P<0.01)。(3)与模型组比较,NRG-1β组心肌胶原容积分数(CVF)下降,心肌中Ang II和TNF-α明显减少,bcl-2 mRNA表达显著升高,而bax mRNA表达下降(P<0.01)。(4)NRG-1β+ HERCE治疗组与模型组相比各项指标无明显改变(P>0.05)。结论:NRG-1可以减少压力超负荷大鼠心肌Ang II和TNF-α的生成,从而减轻Ang II和TNF-α介导的心肌间质重构; NRG-1可通过上调bcl-2 mRNA表达、下调bax mRNA表达,抑制心肌细胞的凋亡,改善压力超负荷大鼠的心功能,进而在心肌肥大的过程中发挥作用。

关 键 词:神经调节蛋白1β  压力超负荷  心肌肥大  
收稿时间:2012-09-28

Therapeutic effect of neuregulin-1β on pressure overload-induced myocardial hypertrophy in rats
LIU Yan-feng , LIU Xiao-juan , HUI Qi-yuan.Therapeutic effect of neuregulin-1β on pressure overload-induced myocardial hypertrophy in rats[J].Chinese Journal of Pathophysiology,2013,29(4):609-614.
Authors:LIU Yan-feng  LIU Xiao-juan  HUI Qi-yuan
Institution:1Medical College of Yanan University, 2Yan’an Health School, Yan’an 716000, China.
Abstract:AIM:To investigate the therapeutic effect and the mechanism of neuregulin-1β (NRG-1β) on the rat model of myocardial hypertrophy induced by pressure  overload.METHODS:Eight weeks after coarctation of abdominal aorta, the Wistar rats were randomly divided into 4 groups: myocardial hypertrophy (model) group, sham operation (sham) group, NRG-1β treatment group (intravenous injection of NRG-1β at dose of 10 μg/kg daily for 7 d) and NRG-1β+Herceptin (HERCE) treatment group [intravenous injection of NRG-1β (10 μg/kg) plus HERCE (10 μg/kg) daily for 7 d]. The characteristics of heart functions were evaluated by the methods of hemodynamics and echocardiography. Masson staining was employed to observe the pathological changes of myocardial tissues. The concentration of angiotensin II (Ang II) in myocardial tissues was measured by radioimmunoassay. The level of tumor necrosis factor α (TNF-α) in myocardial tissues was detected by ELISA. The mRNA expression of B-cell lymphoma/leukemia-2 (bcl-2) and bcl-2-associated X protein (bax) in the myocardium was determined by RT-PCR. RESULTS:The left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS) were higher, while the left ventricular end-systolic diameter (LVESD) and left ventricular end-diastolic diameter (LVEDD) were smaller in NRG-1β group than those in model group. The left ventricular end-systolic pressure (LVESP) and maximal rate of increase/decrease in left ventricular pressure (±dp/dtmax) were higher, and left ventricular end-diastolic pressure (LVEDP) was significantly lower in NRG-1β group than those in model group. Compared with model group, treatment with NRG-1β decreased collagen volume fraction (CVF), reduced the Ang II and TNF-α, increased bcl-2 mRNA expression, and decreased bax mRNA expression in myocardial tissues. No difference of the above parameters between model group and NRG-1β+HERCE treatment group was observed. CONCLUSION:NRG-1 reduces the expression of Ang II and TNF-α in myocardial tissues in pressure-overload rats, thus reducing Ang II and TNF-α mediated myocardial interstitial remodeling. Increase in the mRNA expression of bcl-2 and decrease in the mRNA expression of bax by NRG-1 inhibit myocardial cell apoptosis, which is responsible for its role of improving cardiac function of myocardial hypertrophy induced by pressure overload.
Keywords:Neuregulin-1β  Pressure overload  Myocardial hypertrophy
本文献已被 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号